Literature DB >> 25337415

The mutagenicity analysis of imidapril hydrochloride and its degradant, diketopiperazine derivative, nitrosation mixtures by in vitro Ames test with two strains of Salmonella typhimurium.

Katarzyna Regulska1, Marek Murias2, Beata Stanisz3, Miłosz Regulski2.   

Abstract

AIM: The evaluation of mutagenic properties of imidapril hydrochloride (IMD) and its degradation impurity, diketopiperazine derivative (DKP), nitrosation mixtures was conducted in order to analyze the carcinogenic risk of IMD long-term treatment in patients. In this study an in vitro Ames test with Salmonella enterica serovar Typhimurium TA 98 and TA 100 strains was used.
BACKGROUND: IMD and DKP contain nitrogen atoms, which makes them theoretically vulnerable to in vivo nitrosation with the production of N-nitroso compounds (NOC). NOC, in turn, are known animal mutagens indicating that their endogenous production from nitrosable drugs constitutes a carcinogenic hazard.
MATERIALS AND METHODS: Pure IMD sample was exposed to forced degradation conditions of increased temperature and dry air in order to achieve a DKP sample. Both samples were then treated with a nitrosating agent and the obtained nitrosation mixtures were subjected to mutagenicity analysis by the Ames test with S. typhimurium TA 98 and TA 100 strains in the presence and absence of metabolic activation system (S9 mix) using a commercial Ames MPF 98/100 microplate format mutagenicity assay kit.
RESULTS: None of the six concentrations of the investigated nitrosation mixtures exhibited any mutagenic potential in both S. typhimurium strains. The addition of S9 mix did not alter the non-mutagenic properties of the studied compounds.
CONCLUSIONS: The nitrite treatment of both studied compounds has no impact on their mutagenic properties under the conditions of the present studies. Hence, IMD and DKP nitrosation mixtures are classified as non-mutagens in this test.

Entities:  

Keywords:  Angiotensin-converting enzyme inhibitors; Degradation; Mutagens; N-nitroso compounds

Year:  2014        PMID: 25337415      PMCID: PMC4201778          DOI: 10.1016/j.rpor.2014.04.004

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  15 in total

1.  Optimization of storage and manufacture conditions for imidapril hydrochloride in solid state as a way to reduce costs of antihypertensive therapy.

Authors:  Katarzyna Regulska; Beata Stanisz; Paweł Lisiecki
Journal:  AAPS PharmSciTech       Date:  2013-08-02       Impact factor: 3.246

2.  UV derivative spectrophotometric and RP-HPLC methods for determination of imidapril hydrochloride in tablets and for its stability assessment in solid state.

Authors:  Beata Stanisz; Katarzyna Regulska; Kinga Kolasa
Journal:  Acta Pol Pharm       Date:  2011 Sep-Oct       Impact factor: 0.330

Review 3.  Bacterial mutagenicity screening in the pharmaceutical industry.

Authors:  P A Escobar; R A Kemper; J Tarca; J Nicolette; M Kenyon; S Glowienke; S G Sawant; J Christensen; T E Johnson; C McKnight; G Ward; S M Galloway; L Custer; E Gocke; M R O'Donovan; K Braun; R D Snyder; B Mahadevan
Journal:  Mutat Res       Date:  2012-12-20       Impact factor: 2.433

Review 4.  Significance of multiple mutations in cancer.

Authors:  K R Loeb; L A Loeb
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

Review 5.  Carcinogenic N-nitrosamines in the diet: occurrence, formation, mechanisms and carcinogenic potential.

Authors:  A R Tricker; R Preussmann
Journal:  Mutat Res       Date:  1991 Mar-Apr       Impact factor: 2.433

6.  Alkylating potency of nitrosated amino acids and peptides.

Authors:  S E Shephard; I Meier; W K Lutz
Journal:  IARC Sci Publ       Date:  1991

Review 7.  Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC.

Authors:  S S Mirvish
Journal:  Cancer Lett       Date:  1995-06-29       Impact factor: 8.679

Review 8.  Mutagenic activity of peptides and the artificial sweetener aspartame after nitrosation.

Authors:  S E Shephard; K Wakabayashi; M Nagao
Journal:  Food Chem Toxicol       Date:  1993-05       Impact factor: 6.023

Review 9.  Imidapril: a review of its use in essential hypertension, Type 1 diabetic nephropathy and chronic heart failure.

Authors:  Dean M Robinson; Monique P Curran; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  N-Nitroso compounds and cancer incidence: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study.

Authors:  Yet Hua Loh; Paula Jakszyn; Robert N Luben; Angela A Mulligan; Panagiota N Mitrou; Kay-Tee Khaw
Journal:  Am J Clin Nutr       Date:  2011-03-23       Impact factor: 7.045

View more
  1 in total

1.  Estimation of nizatidine gastric nitrosatability and product toxicity via an integrated approach combining HILIC, in silico toxicology, and molecular docking.

Authors:  Rania El-Shaheny; Mohamed Radwan; Koji Yamada; Mahmoud El-Maghrabey
Journal:  J Food Drug Anal       Date:  2019-08-22       Impact factor: 6.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.